Fed. Circ. Upholds $16.8M Fees Award For Takeda

Takeda Pharmaceutical Co. Ltd. will take home $16.8 million in legal fees after a federal appeals court panel upheld a district court's ruling that generic-drug maker Mylan Laboratories Inc. and subsidiary...

Already a subscriber? Click here to view full article